BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...

LAS VEGAS — Use of a bioconvertible inferior vena cava filter successfully prevented new-onset pulmonary embolism in high-risk patients and was bioresorbed within 1 year in most cases, according to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LAS VEGAS — Use of a bioconvertible inferior vena cava ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry ...

Tamara is a certified copywriter and editor with over four years of experience writing legal content for some of the U.S.' best-known law firms, marketing agencies and legal service providers. She has ...